Randomized Trial of a Postpartum Diabetes Prevention Program for Hispanic Women

西班牙裔妇女产后糖尿病预防计划的随机试验

基本信息

  • 批准号:
    8874207
  • 负责人:
  • 金额:
    $ 50.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-15 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Diabetes and obesity have reached epidemic proportions in the U.S. with rates consistently higher among Hispanic as compared to non-Hispanic whites. Among Hispanic women diagnosed with gestational diabetes mellitus (GDM), 50% will go on to develop type 2 diabetes within 5 years of the index pregnancy. Although randomized controlled trials among adults with impaired glucose tolerance have shown that diet and physical activity reduce the risk of type 2 diabetes, such programs have not been tested in high risk postpartum women. The overall goal of this randomized controlled trial is to test the efficacy of a culturally and linguistically modified, individually-tailored lifestyle intervention o reduce risk factors for type 2 diabetes and cardiovascular disease among postpartum Hispanic women with a history of abnormal glucose tolerance during pregnancy. Specific aims are to evaluate the impact of the intervention on 1) postpartum weight loss, 2) biomarkers associated with insulin resistance (i.e., glucose, insulin, HbA1c, leptin, TNF-, HOMA, AUCgluc, adiponectin), 3) other cardiovascular risk factors (i.e., blood lipids, blood pressure, CRP, fetuin A, albumin-to-creatinine ratio), and 4) the adoption and maintenance of postpartum behaviors associated with weight loss and prevention of diabetes risk (i.e., physical activity, diet). Eligibe Hispanic women will be recruited after routine GDM screening and randomly assigned to a Lifestyle Intervention (n=150) or a Comparison Health and Wellness (control) intervention (n=150). The intervention will be based on our efficacious exercise and dietary interventions for Hispanics (R01NR011295; WIC Common Pathways). Multimodal contacts (i.e., in-person, telephone counseling, and mailed print-based materials) will be used to deliver the intervention from randomization (29 wks gestation) to 12 months postpartum. Targets of the intervention are to achieve Institute of Medicine Guidelines for postpartum weight loss; American College of Obstetrician and Gynecologist guidelines for physical activity; and American Diabetes Association guidelines for diet. The intervention draws from Social Cognitive Theory and the Transtheoretical Model and addresses the specific social, cultural, economic, and physical environmental challenges faced by underserved Hispanic women. Measures of adherence will include accelerometers and dietary recalls.
描述(由申请人提供):糖尿病和肥胖症在美国已经达到流行病的比例,与非西班牙裔白人相比,西班牙裔的发病率一直较高。在被诊断患有妊娠期糖尿病(GDM)的西班牙裔女性中,50%的人将在指数妊娠的5年内发展为2型糖尿病。尽管在葡萄糖耐量受损的成年人中进行的随机对照试验表明,饮食和体力活动可以降低2型糖尿病的风险,但这些计划尚未在高危产后妇女中进行过测试。这项随机对照试验的总体目标是测试一种文化和语言上改良的、个性化定制的生活方式干预的有效性,以减少有妊娠期糖耐量异常史的西班牙裔产后妇女患2型糖尿病和心血管疾病的风险因素。具体目的是评估干预对以下方面的影响:1)产后体重减轻,2)与胰岛素抵抗相关的生物标志物(即,葡萄糖、胰岛素、HbA 1c、瘦素、TNF-α、HOMA、AUCgluc、脂联素),3)其它心血管危险因素(即,血脂、血压、CRP、胎球蛋白 A,白蛋白与肌酸酐比率),和4)采用和维持与体重减轻和预防糖尿病风险相关的产后行为(即,体力活动、饮食)。Eligibe西班牙裔女性将在常规GDM筛查后招募,并随机分配至生活方式干预组(n=150)或健康与健康(对照)干预组(n=150)。干预将基于我们对西班牙裔美国人的有效运动和饮食干预(R 01 NR 011295; WIC共同途径)。多模式接触(即,面对面、电话咨询和邮寄印刷材料)将用于从随机化(妊娠29周)至产后12个月提供干预。干预的目标是实现医学研究所产后减肥指南;美国妇产科医师学院体力活动指南;以及美国糖尿病协会饮食指南。干预借鉴社会认知理论和跨理论模型,并解决了具体的社会,文化,经济和物理环境的挑战所面临的服务不足的西班牙裔妇女。坚持的措施将包括加速计和饮食召回。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LISA CHASAN-TABER其他文献

LISA CHASAN-TABER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LISA CHASAN-TABER', 18)}}的其他基金

Cardiovascular Disease Risk Factors in At-Risk Hispanic Women following Pregnancy Complications
妊娠并发症后高危西班牙裔女性的心血管疾病危险因素
  • 批准号:
    10693125
  • 财政年份:
    2022
  • 资助金额:
    $ 50.79万
  • 项目类别:
Cardiovascular Disease Risk Factors in At-Risk Hispanic Women following Pregnancy Complications
妊娠并发症后高危西班牙裔女性的心血管疾病危险因素
  • 批准号:
    10425763
  • 财政年份:
    2022
  • 资助金额:
    $ 50.79万
  • 项目类别:
Update and Novel Validation of the Pregnancy Physical Activity Questionnaire (PPAQ)
妊娠体力活动问卷 (PPAQ) 的更新和新颖验证
  • 批准号:
    9766345
  • 财政年份:
    2018
  • 资助金额:
    $ 50.79万
  • 项目类别:
Randomized Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women
超重和肥胖西班牙裔孕妇的随机生活方式干预
  • 批准号:
    8578412
  • 财政年份:
    2013
  • 资助金额:
    $ 50.79万
  • 项目类别:
Randomized Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women
超重和肥胖西班牙裔孕妇的随机生活方式干预
  • 批准号:
    9044766
  • 财政年份:
    2013
  • 资助金额:
    $ 50.79万
  • 项目类别:
Randomized Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women
超重和肥胖西班牙裔孕妇的随机生活方式干预
  • 批准号:
    8835097
  • 财政年份:
    2013
  • 资助金额:
    $ 50.79万
  • 项目类别:
Randomized Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women
超重和肥胖西班牙裔孕妇的随机生活方式干预
  • 批准号:
    8707444
  • 财政年份:
    2013
  • 资助金额:
    $ 50.79万
  • 项目类别:
An Exercise Intervention to Prevent Recurrent GDM
预防妊娠期糖尿病复发的运动干预
  • 批准号:
    8059522
  • 财政年份:
    2010
  • 资助金额:
    $ 50.79万
  • 项目类别:
An Exercise Intervention to Prevent Recurrent GDM
预防妊娠期糖尿病复发的运动干预
  • 批准号:
    7209667
  • 财政年份:
    2007
  • 资助金额:
    $ 50.79万
  • 项目类别:
An Exercise Intervention to Prevent Recurrent GDM
预防妊娠期糖尿病复发的运动干预
  • 批准号:
    7339667
  • 财政年份:
    2007
  • 资助金额:
    $ 50.79万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 50.79万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了